<DOC>
	<DOCNO>NCT01018095</DOCNO>
	<brief_summary>The purpose study determine 2 gram single dose metronidazole effective 7 day 500 mg BID dose treatment Trichomonas vaginalis ( TV ) among HIV-infected woman .</brief_summary>
	<brief_title>Trichomonas Vaginalis Recurrence Among HIV+ Women</brief_title>
	<detailed_description>This Phase IV equivalency trial dos metronidazole list Centers Disease Control Prevention Treatment Guidelines treatment T vaginalis .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Trichomonas Infections</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Female 18 year older HIVpositive TV positive either wet preparation culture ability refrain alcohol use 24 hour take oral metronidazole willing take metronidazole treatment pregnant incarcerate previously enrol currently take disulfiram alcoholism know liver damage medical contraindication metronidazole treat metronidazole within previous 14 day require treatment B.V. per Amsel 's criterion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>